GeneDx Holdings Corp. CFO Kevin Feeley exercised Options for 717 shares at $0 per share on Sept. 1, 2026. His reported ownership stood at 40,671 shares after the exercise, while a separate sale at $83.84 per share left him with 40,299 shares, giving investors the transaction-linked ownership figures.

Key Highlights

  • Kevin Feeley’s reported ownership reached 40,671 shares after the option exercise.
  • A separate transaction involving GeneDx Holdings shares was priced at $83.84 per share.
  • Feeley’s reported ownership stood at 40,299 shares after the sale.

GeneDx Holdings Corp. (NASDAQ: WGS) CFO Kevin Feeley exercised options for 717 shares at $0 per share on Sept. 1, 2026. A separate sale at $83.84 per share followed on the same date, with his reported ownership later standing at 40,299 shares.

$0 Option Exercise and Subsequent Share Sale

Feeley’s reported position after the option exercise was 40,671 shares. The exercise and the sale were recorded as separate transactions involving GeneDx Holdings shares. The option exercise used transaction code M, while the sale used transaction code S. The exercise price was $0 per share, and the later sale was priced at $83.84 per share. The transactions occurred on Sept. 1, 2026. The ownership figures correspond to the separate stages of the activity: 40,671 shares after the option exercise and 40,299 shares after the subsequent sale.